Universitat Politecnica de Valencia, Spain.
Universitat Politecnica de Valencia, Spain.
Health Policy. 2020 Aug;124(8):895-901. doi: 10.1016/j.healthpol.2020.05.013. Epub 2020 May 27.
In this paper we investigate to which point each of the healthcare industry's stakeholders are influencing the final innovation outputs. We propose and test a model that puts together stakeholders' engagement, innovation objectives and innovation outputs. We analyze data from 400+ healthcare Spanish companies using Partial Least Squared modelling technique. Results show that stakeholders' engagement is crucial to orientate innovation objectives that are directly and positively related to innovation outputs. Also, results push to a higher implication of society in the co-creation and participation in innovation activities in the healthcare industry highlighting its importance as, both, triggers and the most benefited recipients. This paper uncovers the relationship among healthcare stakeholders and innovation outputs and also answers another research question-which stakeholders have a stronger relationship with innovation outputs. Implications suggest that healthcare industry managers and policy makers should build on the relationship with clients/customers/patients/final users as innovation-related information inputs as an effective way to improve their innovation outputs.
在本文中，我们研究了医疗保健行业的每个利益相关者在多大程度上影响最终的创新成果。我们提出并测试了一个将利益相关者的参与、创新目标和创新成果结合在一起的模型。我们使用偏最小二乘建模技术分析了来自 400 多家西班牙医疗保健公司的数据。结果表明，利益相关者的参与对于指导创新目标至关重要，而创新目标与创新成果直接且呈正相关。此外，研究结果还表明，社会应该更多地参与到医疗保健行业的共同创造和创新活动中，突出其作为创新触发器和最大受益者的重要性。本文揭示了医疗保健利益相关者与创新成果之间的关系，同时回答了另一个研究问题——哪些利益相关者与创新成果的关系更密切。研究结果表明，医疗保健行业的管理者和政策制定者应该建立在与客户/患者/最终用户的关系上，将创新相关的信息作为提高创新成果的有效途径。
